San Francisco, CA, United States of America

Wei Xu

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Xu. Retrieved from https://idiyas.com/inventor/wei-xu-2afy7gzx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Wei Xu in Anti-Cancer Compounds

Introduction

Wei Xu is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer and fibrosis. His work is vital in advancing treatment options for these serious diseases.

Latest Patents

Wei Xu holds a patent for anti-cancer and anti-fibrosis compounds. This invention provides, among other things, compounds useful for treating diseases such as fibrosis and cancer. It also includes pharmaceutical formulations containing these compounds, as well as combinations with at least one additional therapeutic agent. His innovative approach has the potential to improve therapeutic outcomes for patients suffering from these conditions.

Career Highlights

Wei Xu is affiliated with the University of California, where he conducts research and develops new therapeutic strategies. His work is characterized by a commitment to addressing critical health challenges through innovative solutions. With a focus on practical applications, he aims to translate his research into real-world benefits for patients.

Collaborations

Wei Xu collaborates with notable colleagues, including David Jablons and Liang You. These partnerships enhance the research efforts and contribute to the development of effective treatments in the field of oncology and fibrosis.

Conclusion

Wei Xu's contributions to the development of anti-cancer and anti-fibrosis compounds represent a significant advancement in medical research. His innovative work at the University of California continues to pave the way for new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…